Dr. Axe Wire · Food, herbs & supplements · health

Rhodiola Compound Protects Mouse Brains From Alzheimer's-Like Damage

A Rhodiola rosea compound restored memory and brain cell health in mice with chemically induced Alzheimer's-like damage.

By Dr. Josh Axe · November 13, 2026 · 1 source · Watch

Photo: Pexels

At a glance

What they found: Mice with Alzheimer's-like brain damage had better learning and memory after salidroside, with less amyloid buildup and brain shrinkage.
Who was studied: Mice with Alzheimer's-like damage from aluminum chloride and D-galactose, treated with saline, salidroside or donepezil.
What it doesn't show: Whether it works the same way in people.

A compound found in the herb Rhodiola rosea reversed Alzheimer's-like brain damage in mice, according to a study published November 3, 2026 in Phytotherapy Research.

Researchers gave mice aluminum chloride and D-galactose to trigger Alzheimer's-like brain damage, then treated them with saline, salidroside, or the drug donepezil. Salidroside-treated mice showed better learning and memory, less amyloid buildup in the hippocampus (the brain's memory center), less brain shrinkage, and less nerve cell damage than untreated mice. The compound also calmed overactive immune cells in the brain, lowered inflammation and oxidative stress markers, and restored synapse structure along with the proteins that keep those connections working. A separate lab-dish test using glutamate-damaged brain cells confirmed the pathway: blocking a protein called Nrf2 canceled salidroside's protective effect.

Metabolic testing showed salidroside corrected disruptions in how the hippocampus makes and uses glutathione, the brain's main internal antioxidant. The authors reported that salidroside raised glutathione-making enzymes, lowered a suppressor protein called Keap1, and increased the amount of Nrf2, the protein that switches on glutathione production, inside brain cell nuclei.

The authors' findings point to a specific route: salidroside's protective effect depended on activating the Keap1/Nrf2/glutathione pathway, the cell's built-in system for clearing oxidative damage. Blocking that pathway in the lab-dish test erased the protection, which the authors say supports this mechanism.

6mice

Number of mice in the treatment group given salidroside in this study

Phytotherapy Research, 2026, Cui et al.

This is animal and cell-based evidence, not a human trial, so dose, safety and effectiveness in people are next for research. The donepezil comparison lacked matched numbers, and the abstract does not report effect sizes or how long protection lasted.

Dr. Axe’s Take

Rhodiola rosea has long been used as an adaptogenic herb for stress and fatigue, and this mouse data points to its main compound working by switching on the brain's own antioxidant machinery through the Nrf2 pathway, not just blunting stress hormones. The rebuilt synapses and reduced amyloid buildup in these mice are worth watching. I would focus on supporting your own glutathione production with sulfur-rich foods like garlic, onions and cruciferous vegetables, plus quality sleep, since glutathione recycling happens heavily during deep sleep. Keep taking any prescribed Alzheimer's medication exactly as directed; this research does not change that.

— Dr. Axe

Take the Cellular Health Quiz →

Story summary

Who: Mice with Alzheimer's-like brain damage from aluminum chloride and D-galactose; a glutamate-damaged brain cell model was used separately.
Design: Animal and cell study using behavioral tests, brain tissue staining, protein analysis, metabolomics, and network pharmacology/docking to study mechanism.
Dose: Not reported in the abstract; groups were saline, salidroside, or donepezil.
Primary result: Salidroside improved learning and memory, reduced amyloid buildup, brain shrinkage and nerve damage versus untreated mice; effect sizes not reported.
Secondary: Restored synapse structure and proteins; corrected hippocampal glutathione metabolism; raised glutathione-making enzymes; lowered Keap1; increased nuclear Nrf2.
Funding / conflicts: Funder listed in the journal record: National Natural Science Foundation of China. Conflicts not reported in the abstract.
Date: Nov 3, 2026